Results 191 to 200 of about 53,788 (241)
Some of the next articles are maybe not open access.
Pediatrics in Review, 2023
Juvenile idiopathic arthritis (JIA) comprises a group of heterogenous disorders characterized by childhood-onset chronic joint inflammation. It is the most common rheumatologic disease in the pediatric population and an important cause of chronic illness in children.
Andrew M, Long, Bethany, Marston
openaire +2 more sources
Juvenile idiopathic arthritis (JIA) comprises a group of heterogenous disorders characterized by childhood-onset chronic joint inflammation. It is the most common rheumatologic disease in the pediatric population and an important cause of chronic illness in children.
Andrew M, Long, Bethany, Marston
openaire +2 more sources
The Lancet, 2007
Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background.
RAVELLI, ANGELO, MARTINI, ALBERTO
openaire +3 more sources
Juvenile idiopathic arthritis is a broad term that describes a clinically heterogeneous group of arthritides of unknown cause, which begin before 16 years of age. This term encompasses several disease categories, each of which has distinct methods of presentation, clinical signs, and symptoms, and, in some cases, genetic background.
RAVELLI, ANGELO, MARTINI, ALBERTO
openaire +3 more sources
Autoimmunity Reviews, 2006
One of the most enigmatic problems in rheumatology has been juvenile idiopathic arthritis (JIA). Firstly, the classification has often depended on clinical features that have variations between patients. Secondly, there are different classification schemes in usage and there are few objective serologic tests that help to resolve the differences between
A. T. Borchers +5 more
openaire +2 more sources
One of the most enigmatic problems in rheumatology has been juvenile idiopathic arthritis (JIA). Firstly, the classification has often depended on clinical features that have variations between patients. Secondly, there are different classification schemes in usage and there are few objective serologic tests that help to resolve the differences between
A. T. Borchers +5 more
openaire +2 more sources
Pharmacosurveillance in Juvenile Idiopathic Arthritis
Rheumatic Disease Clinics of North America, 2021The advent of biologic disease-modifying antirheumatic drugs targeting specific cytokines or cell-cell interactions has dramatically changed the outlook of patients with juvenile idiopathic arthritis. However, safety concerns remain around the use of therapeutic agents for children with juvenile idiopathic arthritis.
Natalie J, Shiff, Timothy, Beukelman
openaire +2 more sources
Nederlands Tijdschrift voor Tandheelkunde, 2018
Juvenile idiopathic arthritis (JIA) is the most common cause of chronic inflammation of the joints in childhood. Currently, JIA is divided into 7 subtypes, distinguished on the basis of the symptoms present in the first six months of the illness. Pharmacological treatment is different for every subtype. With all forms of JIA, dental problems can occur.
Schatorje, E.J., Royen-Kerkhof, A. Van
openaire +3 more sources
Juvenile idiopathic arthritis (JIA) is the most common cause of chronic inflammation of the joints in childhood. Currently, JIA is divided into 7 subtypes, distinguished on the basis of the symptoms present in the first six months of the illness. Pharmacological treatment is different for every subtype. With all forms of JIA, dental problems can occur.
Schatorje, E.J., Royen-Kerkhof, A. Van
openaire +3 more sources
Current Opinion in Rheumatology, 2001
A significant amount of work has been performed over the past 2 years further defining the pathophysiology of juvenile idiopathic arthritis (JIA). The development of the biologic agent etanercept represents successful translational research. This genetically engineered fusion protein targets tumor necrosis factor, binding and inactivating this ...
D T, Kulas, L, Schanberg
openaire +2 more sources
A significant amount of work has been performed over the past 2 years further defining the pathophysiology of juvenile idiopathic arthritis (JIA). The development of the biologic agent etanercept represents successful translational research. This genetically engineered fusion protein targets tumor necrosis factor, binding and inactivating this ...
D T, Kulas, L, Schanberg
openaire +2 more sources
The Lancet, 2011
Juvenile idiopathic arthritis is a heterogeneous group of diseases characterised by arthritis of unknown origin with onset before age of 16 years. Pivotal studies in the past 5 years have led to substantial progress in various areas, ranging from disease classification to new treatments.
Prakken B, Albani S, MARTINI, ALBERTO
openaire +3 more sources
Juvenile idiopathic arthritis is a heterogeneous group of diseases characterised by arthritis of unknown origin with onset before age of 16 years. Pivotal studies in the past 5 years have led to substantial progress in various areas, ranging from disease classification to new treatments.
Prakken B, Albani S, MARTINI, ALBERTO
openaire +3 more sources
Rheumatic Disease Clinics of North America, 2005
Juvenile idiopathic arthritis (JIA), a term referring to a group of disorders characterized by chronic arthritis, is the most common chronic rheumatic illness in children and is a significant cause of short- and long-term disability. This article discusses the classification, differential diagnosis, and treatment of JIA.
Jennifer E, Weiss, Norman T, Ilowite
openaire +3 more sources
Juvenile idiopathic arthritis (JIA), a term referring to a group of disorders characterized by chronic arthritis, is the most common chronic rheumatic illness in children and is a significant cause of short- and long-term disability. This article discusses the classification, differential diagnosis, and treatment of JIA.
Jennifer E, Weiss, Norman T, Ilowite
openaire +3 more sources
New England Journal of Medicine
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The International League of Associations for Rheumatology (ILAR) has defined JIA as "arthritis of unknown etiology persisting for ≥6 wk with an onset at
Christy I. Sandborg +2 more
openaire +4 more sources
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The International League of Associations for Rheumatology (ILAR) has defined JIA as "arthritis of unknown etiology persisting for ≥6 wk with an onset at
Christy I. Sandborg +2 more
openaire +4 more sources
The Etiology of Juvenile Idiopathic Arthritis
Clinical Reviews in Allergy & Immunology, 2014Over the years, the commonly used term to describe juvenile idiopathic arthritis (JIA) has changed. By definition, JIA includes all types of arthritis with no apparent cause, lasting more than 6 weeks, in patients aged less than 16 years at onset. JIA pathogenesis is still poorly understood: the interaction between environmental factors and multiple ...
Rigante, Donato, Bosco, A, Esposito, S.
openaire +3 more sources